Hybridoma vs Phage Display: Choosing the Right Platform for Monoclonal Antibody Discovery Introduction Monoclonal antibody discovery relies mainly on two established platforms: hybridoma technology and display-based antibody selection, including phage display and yeast display. Both approaches have contributed significantly to research and therapeutic antibody development, but their advantages depend on target properties, project timelines, and …
Hybridoma vs Phage Display: Choosing the Right Platform for Monoclonal Antibody Discovery